Keybanc Maintains Overweight on Corteva, Lowers Price Target to $14
Keybanc analyst Salvator Tiano maintains Corteva (NYSE:CTVA) with a Overweight and lowers the price target from $17 to $14.
Follow the latest Corteva, Inc. (CTVA) news and market headlines alongside the live CTVA price. Stay informed on what's moving CTVA.
Keybanc analyst Salvator Tiano maintains Corteva (NYSE:CTVA) with a Overweight and lowers the price target from $17 to $14.
JP Morgan analyst Jeffrey Zekauskas maintains Corteva (NYSE:CTVA) with a Overweight and lowers the price target from $19 to $16.
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $15 to $10.
RBC Capital analyst Arun Viswanathan maintains Corteva (NYSE:CTVA) with a Outperform and lowers the price target from $17 to $11.
Corteva stock plummeted 20.2% after missing Q3 earnings expectations, reporting $0.06 per share instead of the anticipated $0.10, with sales below $1.6 billion versus expected $1.8 billion. The miss was driven by rapid price declines in agricultural chemicals, particularly in Latin America where sales fell 28% year-over-year. Management expects challenging market conditions ahead, especially in Brazil, though full-year guidance remains between $0.76-$0.80 per share on an adjusted basis—below Wall Street's GAAP expectations of $0.82.
U.S. futures were mixed as Corteva plunged 8% after missing earnings and sales estimates; Digi, Nvidia, quantum stocks and others also fell premarket.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to CTVA, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.